Annual Report

Overview

The report describes a year of growth and operational expansion for the company, with consolidated revenue from operations of ₹ 110,658.11 lakhs. It highlights eight domestic product launches across cardiac, anti-diabetic, and dermatology segments. The company also maintained manufacturing and supply activities during the COVID-19 disruption and spent ₹ 92.91 Lakhs on CSR initiatives, including education, healthcare, vocational skills, and COVID-19 relief.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019-2020
Period: 1 April 2019 – 31 March 2020
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services